We verified some of the biological functions of FOXD2-AS1 through in vitro experiments and found that knocking down the expression of FOXD2-AS1 could reduce the proliferation and migration of ccRCC cells. This evidence concerns the gene FOXD2 and nonpapillary renal cell carcinoma.